-
Creative Biogene announced the release of one-stop C. elegans aging research services to accelerate the speed of partners’ aging studies.
Mar 30, 2022
-
ScitoVation has announced that Jeffrey W. Fisher, PhD has been awarded the 2022 Society of Toxicology (SOT) Arnold J. Lehman Award.
Mar 14, 2022
-
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance.
Feb 1, 2022
-
The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics recently launched various types of genotyping analysis services, including analysis of data generated by different classification techniques, such as whole-genome sequencing, whole-exome sequencing, whole-genome SNP chips, and mass spectrometry.
Feb 9, 2022
-
As a reliable computational biology service provider based in New York, CD ComputaBio has recently launched homology modeling service to help researchers deeply understand the structure-activity relationship of the target protein, and provide strong support for structure-based rational drug design, protein function research, and protein engineering research. Relying on its professional team and advanced technology, as well as high-quality products and services, CD ComputaBio has gained a solid reputation.
Feb 21, 2022
-
CD ComputaBio, a reliable computational biology service provider located in New York, always hammers at researches and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. Recently, the product manager announced the launch of molecular docking service, which has a wide range of applications in the field of enzymology research and drug design.
Feb 13, 2022
-
Molecular diagnostics company ChromaCode receives expanded EUA authorization for its high throughput HDPCR SARS-Co-V-2 real time PCR assay to include several new qPCR instruments and use of 384-well plates.
Feb 22, 2022
-
Creative Biogene has become the premier partner to cooperate in the exploration of the pathogenesis of mitochondrial-associated diseases.
Feb 23, 2022
-
Pronalyse, a new division of Creative Proteomics, is an integrated CRO company with rich experience in providing drug development services for over 10 years. Creative Proteomics Pronalyse recently announced the launch of antibody-drug conjugates (ADCs) characterization service to ensure the safety and effectiveness of ADCs drugs.
Feb 14, 2022
-
As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnological and pharmaceutical companies. The company has recently announced the launch of fully-developed lipidomics bioinformation analysis service to screen differential lipid molecules and analyze their pathways, revealing the physiological mechanism of their changes.
Feb 10, 2022
-
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. With deep industry and business process expertise and a good reputation in providing contract services specialized for metabolomics, Creative Proteomics Metabolomics announced the launch of microbial metabolomics service to promote a comprehensive understanding of microbial physiology.
Feb 8, 2022
-
VERICHEM offers clinical laboratories their liquid stable and ready-to-use MATRIX PLUS™ Chemistry Reference Materials which are expressly designed for the calibration and calibration verification of chemistry assays and to support overall system QC and CLIA compliance.
Feb 28, 2022
-
Mar 1, 2022
-
Mar 1, 2022
-
Mar 1, 2022
-
Mar 1, 2022
-
Mar 1, 2022
-
Mar 1, 2022
-
As a New York-based CRO company, CD Formulation has keenly observed that the demand for tailored pharmaceutical excipients is on the rise, especially over the past decade, as each formulation project may need unique excipients. In response to such a market trend, the management of CD Formulation earlier this month announces to offer customized synthesis for lipid excipients, which are used in lipid-based dosage forms for the enhancement of drug absorption or delivery.
Mar 1, 2022
-
Mar 1, 2022